Neuberger Berman Group »

Taysha Gene Therapies shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 11k 4.47

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Nextera Energy Common (NEE)
Home Depot Common (HD)
Exxon Mobil Corp Common (XOM)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
FMR
Rtw Investments
State Street Corporation
Vanguard Capital Management
Octagon Capital Advisors
Siren
Polar Capital Holdings
Geode Capital Management
D. E. Shaw & Co

View all funds holding Taysha Gene Therapies